AN2 Therapeutics, Inc.
ANTX
$1.15
$0.043.60%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -39.82% | -41.28% | -22.07% | -24.55% | 9.74% |
| Total Receivables | 33.33% | -- | -78.57% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 61.97% | 4.56% | 29.36% | 25.94% | -11.48% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -37.15% | -40.20% | -21.94% | -22.72% | 9.40% |
|
|
|||||
| Total Current Assets | -37.15% | -40.20% | -21.94% | -22.72% | 9.40% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -70.85% | -22.91% | -- | 44.86% |
| Total Assets | -30.10% | -32.92% | -33.63% | -36.49% | 9.66% |
|
|
|||||
| Total Accounts Payable | 12.10% | 26.30% | 23.95% | -64.92% | -39.80% |
| Total Accrued Expenses | -45.95% | -42.19% | -42.70% | -21.76% | -1.78% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 28.26% | 14.95% | 18.41% | 30.64% | 186.67% |
| Total Other Current Liabilities | 28.26% | 14.95% | 18.41% | 30.64% | 186.67% |
| Total Current Liabilities | -31.05% | -24.84% | -27.10% | -32.50% | -9.26% |
|
|
|||||
| Total Current Liabilities | -31.05% | -24.84% | -27.10% | -32.50% | -9.26% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -31.05% | -24.84% | -27.10% | -32.50% | -9.27% |
|
|
|||||
| Common Stock & APIC | 2.75% | 2.87% | 3.12% | 3.31% | 36.01% |
| Retained Earnings | -20.15% | -26.51% | -33.23% | -44.12% | -53.50% |
| Treasury Stock & Other | 192.59% | -9.43% | -88.73% | 191.80% | 77.31% |
| Total Common Equity | -30.01% | -33.70% | -34.36% | -36.91% | 12.07% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -30.01% | -33.70% | -34.36% | -36.91% | 12.07% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -30.01% | -33.70% | -34.36% | -36.91% | 12.07% |
|
|
|||||